N
146.39
7.10 (5.10%)
| Previous Close | 139.29 |
| Open | 139.43 |
| Volume | 389,952 |
| Avg. Volume (3M) | 462,845 |
| Market Cap | 5,266,180,096 |
| Price / Earnings (TTM) | 100.27 |
| Price / Sales | 5.05 |
| Price / Book | 6.00 |
| 52 Weeks Range | |
| Earnings Date | 24 Feb 2026 |
| Profit Margin | 7.42% |
| Operating Margin (TTM) | 12.84% |
| Diluted EPS (TTM) | 1.95 |
| Quarterly Revenue Growth (YOY) | 1.10% |
| Quarterly Earnings Growth (YOY) | 44.50% |
| Total Debt/Equity (MRQ) | 57.49% |
| Current Ratio (MRQ) | 2.56 |
| Operating Cash Flow (TTM) | 157.37 M |
| Levered Free Cash Flow (TTM) | 152.43 M |
| Return on Assets (TTM) | 5.75% |
| Return on Equity (TTM) | 9.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (US) | Bullish | Mixed |
| Scientific & Technical Instruments (Global) | Bullish | Mixed | |
| Stock | Novanta Inc. | Mixed | Bearish |
AIStockmoo Score
-2.2
| Analyst Consensus | 2.0 |
| Insider Activity | -5.0 |
| Price Volatility | -4.0 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | -0.5 |
| Average | -2.20 |
|
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Core |
| % Held by Insiders | 0.86% |
| % Held by Institutions | 105.06% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BUCKLEY ROBERT | - | 143.57 | -6,652 | -947,107 |
| BURKE JOHN JOSEPH II | - | 141.93 | -487 | -69,251 |
| GLASTRA MATTHIJS | - | 142.78 | -11,605 | -1,645,264 |
| LESICA JOHN | - | 145.80 | -925 | -134,866 |
| RAVETTO CHARLES GUY JR | - | 142.68 | -1,285 | -184,116 |
| Aggregate Net Quantity | -20,954 | |||
| Aggregate Net Value ($) | -2,980,604 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 143.17 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GLASTRA MATTHIJS | Officer | 24 Feb 2026 | Disposed (-) | 5,247 | 137.44 | 721,148 |
| GLASTRA MATTHIJS | Officer | 24 Feb 2026 | Option execute | 10,852 | - | - |
| BURKE JOHN JOSEPH II | Officer | 24 Feb 2026 | Disposed (-) | 141 | 137.44 | 19,379 |
| BURKE JOHN JOSEPH II | Officer | 24 Feb 2026 | Option execute | 479 | - | - |
| BUCKLEY ROBERT | Officer | 24 Feb 2026 | Disposed (-) | 2,624 | 137.44 | 360,643 |
| BUCKLEY ROBERT | Officer | 24 Feb 2026 | Option execute | 5,426 | - | - |
| RAVETTO CHARLES GUY JR | Officer | 24 Feb 2026 | Disposed (-) | 243 | 137.44 | 33,398 |
| RAVETTO CHARLES GUY JR | Officer | 24 Feb 2026 | Option execute | 825 | - | - |
| RAVETTO CHARLES GUY JR | Officer | 23 Feb 2026 | Disposed (-) | 311 | 142.38 | 44,280 |
| RAVETTO CHARLES GUY JR | Officer | 23 Feb 2026 | Option execute | 1,059 | - | - |
| BURKE JOHN JOSEPH II | Officer | 23 Feb 2026 | Disposed (-) | 176 | 142.38 | 25,059 |
| BURKE JOHN JOSEPH II | Officer | 23 Feb 2026 | Option execute | 519 | - | - |
| LESICA JOHN | Officer | 20 Feb 2026 | Disposed (-) | 480 | 145.96 | 70,061 |
| LESICA JOHN | Officer | 20 Feb 2026 | Option execute | 1,633 | - | - |
| RAVETTO CHARLES GUY JR | Officer | 20 Feb 2026 | Disposed (-) | 480 | 145.96 | 70,061 |
| RAVETTO CHARLES GUY JR | Officer | 20 Feb 2026 | Option execute | 1,633 | - | - |
| GLASTRA MATTHIJS | Officer | 20 Feb 2026 | Disposed (-) | 2,574 | 145.96 | 375,701 |
| GLASTRA MATTHIJS | Officer | 20 Feb 2026 | Option execute | 5,322 | - | - |
| BUCKLEY ROBERT | Officer | 20 Feb 2026 | Disposed (-) | 1,185 | 145.96 | 172,963 |
| BUCKLEY ROBERT | Officer | 20 Feb 2026 | Automatic sell (-) | 1,423 | 145.96 | 207,701 |
| BUCKLEY ROBERT | Officer | 20 Feb 2026 | Option execute | 3,873 | - | - |
| BURKE JOHN JOSEPH II | Officer | 20 Feb 2026 | Disposed (-) | 170 | 145.96 | 24,813 |
| BURKE JOHN JOSEPH II | Officer | 20 Feb 2026 | Option execute | 490 | - | - |
| BUCKLEY ROBERT | Officer | 19 Feb 2026 | Disposed (-) | 1,420 | 144.93 | 205,801 |
| BUCKLEY ROBERT | Officer | 19 Feb 2026 | Option execute | 2,935 | - | - |
| RAVETTO CHARLES GUY JR | Officer | 19 Feb 2026 | Disposed (-) | 251 | 144.93 | 36,377 |
| RAVETTO CHARLES GUY JR | Officer | 19 Feb 2026 | Option execute | 722 | - | - |
| GLASTRA MATTHIJS | Officer | 19 Feb 2026 | Disposed (-) | 3,784 | 144.93 | 548,415 |
| GLASTRA MATTHIJS | Officer | 19 Feb 2026 | Option execute | 7,825 | - | - |
| LESICA JOHN | Officer | 18 Feb 2026 | Disposed (-) | 445 | 145.63 | 64,805 |
| LESICA JOHN | Officer | 18 Feb 2026 | Option execute | 1,388 | - | - |
| Show more | ||||||
| Date | Type | Details |
|---|---|---|
| 22 Jan 2026 | Announcement | Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026 |
| 18 Dec 2025 | Announcement | Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026 |
| 15 Dec 2025 | Announcement | Novanta to Present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |